Initial blood work found hints of an infection, and the doctors initially suspected a bacterial skin infection (cellulitis) ...
Prominent Nontuberculous Mycobacterial (NTM) Infections emerging therapies include ALIS, Antimycobacterial regimen, ...
“If someone does not take proper treatment for tuberculosis, it can ultimately lead to the death to the patient,” warns ...
After assessing data from the first 46 adults with refractory nontuberculous mycobacterial lung disease who completed the ...
Men and women with chronic obstructive pulmonary disease (COPD), bronchiectasis, and nontuberculous mycobacterial (NTM) lung ...
One of the most common genetic diseases, AATD, involves the retention of misfolded alpha 1 antitrypsin (AAT) in hepatocytes, which ...
Tuberculosis (TB) is one of the world’s most common infectious diseases. Although infection with the Mycobacterium tuberculosis bacterium primarily affects the lungs, up to 25 percent of all infected ...
Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium ...
MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation suspension for ...
Tuberculosis is one of the world's leading infectious diseases. Infection with the bacterium Mycobacterium tuberculosis primarily affects the lungs, but in up to 25 percent of all infected individuals ...
A new nano-based drug delivery technology could outwit tuberculosis (TB)—one of humanity's most ancient diseases. At the Wits Advanced Drug Delivery Platform (WADDP), postdoctoral researcher Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback